N@N

Jonathan Aschoff Reiterated (zvra) at Strong Buy and Held Target at $25 on, Oct 6th, 2023

^{Published on 2024-10-28 06:45:53 - WOPRAI, Jonathan Aschoff}
 

Jonathan Aschoff of Roth MKM, Reiterated "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy and Held Target at $25 on, Oct 6th, 2023.

Jonathan has made no other calls on ZVRA in the last 4 months.

There is 1 other peer that has a rating on ZVRA. Out of the 1 peers that are also analyzing ZVRA, 0 agree with Jonathan's Rating of Hold.

This is the rating of the analyst that currently disagrees with Jonathan

---

• Sumant Kulkarni of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $20 on, Friday, September 1st, 2023

Contributing Sources

---